Cargando…

Prognostic Role of Albumin, Bilirubin, and ALBI Scores: Analysis of 1000 Patients with Hepatocellular Carcinoma Undergoing Radioembolization

Introduction: We compared the efficacy of the ALBI (albumin–bilirubin) score to the established Child–Pugh (CP) grade in hepatocellular carcinoma (HCC) patients treated with yttrium-90 radioembolization (Y90). We further assessed the individual contributions of albumin and bilirubin to survival pred...

Descripción completa

Detalles Bibliográficos
Autores principales:	Antkowiak, Mark, Gabr, Ahmed, Das, Arighno, Ali, Rehan, Kulik, Laura, Ganger, Daniel, Moore, Christopher, Abecassis, Michael, Katariya, Nitin, Mouli, Samdeep, Mahalingam, Devalingam, Lewandowski, Robert J., Salem, Riad, Riaz, Ahsun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627853/ https://www.ncbi.nlm.nih.gov/pubmed/31238514 http://dx.doi.org/10.3390/cancers11060879

Ejemplares similares

Side Effects of Yttrium-90 Radioembolization
por: Riaz, Ahsun, et al.
Publicado: (2014)

Current State of Liver-Directed Therapies and Combinatory Approaches with Systemic Therapy in Hepatocellular Carcinoma (HCC)
por: Viveiros, Pedro, et al.
Publicado: (2019)

Preoperative portal vein recanalization–transjugular intrahepatic portosystemic shunt for chronic obliterative portal vein thrombosis: Outcomes following liver transplantation
por: Talwar, Abhinav, et al.
Publicado: (2022)

Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study
por: Salem, Riad, et al.
Publicado: (2021)

Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
por: Kallini, Joseph Ralph, et al.
Publicado: (2016)

Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade
por: Liao, Jia-I, et al.
Publicado: (2023)

The Association of Albumin-Bilirubin (ALBI) Grade with Mortality Risk in Trauma Patients with Liver Injuries
por: Chou, Sheng-En, et al.
Publicado: (2023)

Role of interventional oncology in hepatocellular carcinoma: Future best practice beyond current guidelines
por: Goyal, Piyush, et al.
Publicado: (2022)

Albumin-bilirubin (ALBI) score at admission predicts possible outcomes in patients with acute-on-chronic liver failure
por: Chen, Bo, et al.
Publicado: (2017)

Proton Beam Therapy for Treatment-Naïve Hepatocellular Carcinoma and Prognostic Significance of Albumin-Bilirubin (ALBI) Grade
por: Kim, Tae Hyun, et al.
Publicado: (2022)

In albis : poemas, 1979-1990 /
por: Magaña, Gabriel, 1944-

To determine the prognostic value of the albumin–bilirubin grade (ALBI) in patients underwent transarterial chemoembolization for unresectable hepatocellular carcinoma
por: Khalid, Muhammad Ali, et al.
Publicado: (2019)

Comparison of platelet-albumin-bilirubin (PALBI), albumin-bilirubin (ALBI), and child-pugh (CP) score for predicting of survival in advanced hcc patients receiving radiotherapy (RT)
por: Ho, Connie H.M., et al.
Publicado: (2018)

Albumin - bilirubin (ALBI) versus Child-Turcotte-Pugh (CTP) in prognosis of HCC after stereotactic body radiation therapy
por: Su, Ting-Shi, et al.
Publicado: (2019)

Comparative evaluation of ALBI, MELD, and Child-Pugh scores in prognosis of cirrhosis: is ALBI the new alternative?
por: Fragaki, Maria, et al.
Publicado: (2019)

Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma
por: Mao, Shuqi, et al.
Publicado: (2021)

Machine learning-based normal tissue complication probability model for predicting albumin-bilirubin (ALBI) grade increase in hepatocellular carcinoma patients
por: Prayongrat, Anussara, et al.
Publicado: (2022)

Combined preoperative albumin-bilirubin (ALBI) and serum γ-glutamyl transpeptidase (GGT) predicts the outcome of hepatocellular carcinoma patients following hepatic resection
por: Zhang, Chi-Hao, et al.
Publicado: (2019)

Correction: Machine learning-based normal tissue complication probability model for predicting albumin-bilirubin (ALBI) grade increase in hepatocellular carcinoma patients
por: Prayongrat, Anussara, et al.
Publicado: (2023)

Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study
por: Lee, Soon Kyu, et al.
Publicado: (2019)

Reassessment of the lung dose limits for radioembolization
por: Kappadath, S. Cheenu, et al.
Publicado: (2021)

Percutaneous sequential closure of an Abernethy malformation: A case report
por: Malik, Asad, et al.
Publicado: (2023)

Percutaneous Ultrasound-Guided Superior and Inferior Mesenteric Vein Access for Portal Vein Recanalization–Transjugular Intrahepatic Portosystemic Shunt: A Case Series
por: Entezari, Pouya, et al.
Publicado: (2020)

Trans-cervical thoracic duct embolization for post-surgical left Chylothorax in a patient with multifocal lymphatic malformations
por: Gulaya, Karan, et al.
Publicado: (2021)

Child Pugh and ALBI grade: past, present or future?
por: Rimini, Margherita, et al.
Publicado: (2020)

Genomic sequencing in clinical trials
por: Mestan, Karen K, et al.
Publicado: (2011)

Público y privado : un acuerdo necesario / Emilio Albi.
por: Albi Ibáñez, Emilio
Publicado: (2000)

Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Ho, Shu-Yein, et al.
Publicado: (2023)

The physics of radioembolization
por: Bastiaannet, Remco, et al.
Publicado: (2018)

Is the Y90-radioembolization treatment effective on the intermediate-advanced stage of hepatocellular carcinoma and what is the albumin-bilirubin score’s prediction factor for survival?
por: Evirgen, Sami, et al.
Publicado: (2023)

Combined APRI/ALBI score to predict mortality after hepatic resection
por: Starlinger, P, et al.
Publicado: (2021)

Review: Oncolytic virotherapy, updates and future directions
por: Fountzilas, Christos, et al.
Publicado: (2017)

The Landscape of Targeted Therapies in TNBC
por: Vagia, Elena, et al.
Publicado: (2020)

ALBI Score Is a Strong Predictor of Toxicity Following SIRT for Hepatocellular Carcinoma
por: Lescure, Céline, et al.
Publicado: (2021)

Application of the ALBI Scoring System for Mortality Outcome Prediction in Patients with Hypertrophic Cardiomyopathy
por: Qiao, Ping, et al.
Publicado: (2022)

Baseline ALBI Grade Predicts Benefits After Splenectomy for Cirrhotic Patients with Hypersplenism
por: Zhu, Qi, et al.
Publicado: (2023)

TIPS-17 A FIRST-IN-HUMAN FEASIBILITY STUDY TO EVALUATE THE SAFETY OF SELECTIVE INTRA-ARTERIAL YTTRIUM-90 MICROSPHERE TREATMENT IN PATIENTS WITH RECURRENT GLIOBLASTOMA (THE FRONTIER TRIAL)
por: Mouli, Samdeep, et al.
Publicado: (2023)

The ability of the new ALBI scoring in predicting mortality, complications and prognostic comparison among cirrhotics
por: Naqvi, Iftikhar Haider, et al.
Publicado: (2019)

ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma
por: Demirtas, Coskun O., et al.
Publicado: (2021)

An ALBI- and Ascites-Based Model to Predict Survival for BCLC Stage B Hepatocellular Carcinoma
por: He, Cheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_et2booff0nfs77r2o6lkvasom6